Who owns Crispr Therapeutics Ag call?

Tip: Access positions for across all investors

Analyze quarterly positions in Crispr Therapeutics Ag call with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Crispr Therapeutics Ag call stock

Who bought or sold Crispr Therapeutics Ag call this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
IMC-Chicago 480k $25M 21% Dec 2025
 View chart
Group One Trading 333k $18M 37% Dec 2025
 View chart
Simplex Trading 181k $9.5M -12% Dec 2025
 View chart
National Bank Of Canada /fi/ 2.0k $11M -53% Dec 2025
 View chart
Persistent Asset Partners 258.00 $16k 0% Dec 2025
 View chart

Who sold out of Crispr Therapeutics Ag call?

Fund or Company Name Date Sold Shares Held Valued At
Maven Securities Sep 2025 18k $1.2M